233 related articles for article (PubMed ID: 23846111)
1. Genetic predisposition for development of nephropathy in type 2 diabetes mellitus.
Kumar R; Sharma RK; Agarwal S
Biochem Genet; 2013 Dec; 51(11-12):865-75. PubMed ID: 23846111
[TBL] [Abstract][Full Text] [Related]
2. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients.
El-Baz R; Settin A; Ismaeel A; Khaleel AA; Abbas T; Tolba W; Abd Allah W; Sobh MA
J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):472-7. PubMed ID: 22554825
[TBL] [Abstract][Full Text] [Related]
3. Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran.
Rahimi Z; Hasanvand A; Felehgari V
DNA Cell Biol; 2012 Apr; 31(4):553-9. PubMed ID: 21942443
[TBL] [Abstract][Full Text] [Related]
4. Genetic combination of angiotensin-converting enzyme with methylene tetrahydrofolate reductase polymorphisms and the risk of type 2 diabetes mellitus in Bahrain.
Al-Harbi EM; Farid EM; Gumaa KA; Darwish AH; Alenizi M; Singh J
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):172-7. PubMed ID: 23447104
[TBL] [Abstract][Full Text] [Related]
5. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
Sun J; Xu Y; Zhu Y
Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
[TBL] [Abstract][Full Text] [Related]
6. The relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and diabetic nephropathy in Croatian type 2 diabetic patients.
Tomić NG; Marusić S; Bozikov V; Kusec R; Bacić-Vrca V; Tadić M
Coll Antropol; 2013 Sep; 37(3):789-93. PubMed ID: 24308218
[TBL] [Abstract][Full Text] [Related]
7. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
[TBL] [Abstract][Full Text] [Related]
8. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
[TBL] [Abstract][Full Text] [Related]
9. Relationship between genetic polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase as risk factors for type 2 diabetes in Tunisian patients.
Mehri S; Koubaa N; Nakbi A; Hammami S; Chaaba R; Mahjoub S; Zouari B; Abid M; Ben Arab S; Baudin B; Hammami M
Clin Biochem; 2010 Feb; 43(3):259-66. PubMed ID: 19857476
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus.
Rahimi M; Hasanvand A; Rahimi Z; Vaisi-Raygani A; Mozafari H; Rezaei M; Zargooshi J; Najafi F; Shakiba E
Clin Biochem; 2010 Nov; 43(16-17):1333-9. PubMed ID: 20800057
[TBL] [Abstract][Full Text] [Related]
11. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
[TBL] [Abstract][Full Text] [Related]
12. Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran.
Rahimi Z; Vaisi-Raygani A; Rahimi Z; Parsian A
Nephrology (Carlton); 2012 Feb; 17(2):175-81. PubMed ID: 22026967
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.
Zhou TB; Drummen GP; Jiang ZP; Li HY
Ren Fail; 2015; 37(8):1247-59. PubMed ID: 26161693
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
16. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
17. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
[TBL] [Abstract][Full Text] [Related]
18. Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy.
Shin Shin Y; Baek SH; Chang KY; Park CW; Yang CW; Jin DC; Kim YS; Chang YS; Bang BK
Diabetes Res Clin Pract; 2004 Sep; 65(3):257-65. PubMed ID: 15331206
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
Yu ZY; Chen LS; Zhang LC; Zhou TB
Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
[TBL] [Abstract][Full Text] [Related]
20. Association of methylene tetrahydrofolate reductase C677T genotype with type 2 diabetes mellitus patients with and without renal complications.
Movva S; Alluri RV; Venkatasubramanian S; Vedicherla B; Vattam KK; Ahuja YR; Hasan Q
Genet Test Mol Biomarkers; 2011 Apr; 15(4):257-61. PubMed ID: 21186995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
